Treatment of massive pulmonary embolus with catheter-directed tenecteplase [1]

Journal of Vascular and Interventional Radiology

Volumn 12, Issue 12, 2001, Pages 1456-1457

  Sze, D Y ^a   Lewis Carey, M B ^a   Razavi, M K ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; TENECTEPLASE;

ADULT; ARTERIOGRAPHY; ARTERY CATHETER; BLEEDING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; ECHOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; LETTER; LUNG EMBOLISM; PRIORITY JOURNAL; TECHNIQUE; VENA CAVA FILTER;

EID: 0035211214     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)61710-2     Document Type: Letter

References (10)

1. Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: Review of the clinical literature
2. New plasminogen activators: A clinical review
3. Interventional therapy for pulmonary embolism
4. Alteplase as an alternative to urokinase
5. The safety, efficacy, and pharmacoeconomics of alteplase compared to urokinase for catheter-directed thrombolysis of arterial and venous occlusions
6. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators
7. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator
8. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial
9. The relative rapidity of recanalization induced by recombinant tissue-type plasminogen activator (r-tPA) and TNK-tPA, assessed with enzymatic methods
10. Pharmacokinetics and pharmacodynamics of tenecteplase: Results from a phase II study in patients with acute myocardial infarction